drugset / Trial / NCT03526588
Umbilical Cord Blood Mononuclear Cells for Hypoxic Neurologic Injury in Infants With Congenital Diaphragmatic Hernia (CDH)
Phase 1
Terminated
3 enrolled
The University of Texas Health Science Center, Houston
Texas Medical Center Regenerative Medicine Consortium · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate the use of autologous umbilical cord blood (UCB) mononuclear cells to mitigate hypoxic neurologic injury among infants with high-risk congenital diaphragmatic hernia (CDH).
Timeline
- Start
- 2018-08-01
- Primary completion
- 2022-07-01
- Completion
- 2024-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Autologous cord blood | Cell therapy | 6e+06 cells | Intravenous |